It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Prognostic factors for overall survival (OS), percutaneous endoscopic gastrostomy (PEG) dependency, and long-term speech rehabilitation via voice prosthesis (VP) after laryngectomy for laryngeal or hypopharyngeal cancer were investigated in a retrospective population-based study in Thuringia, Germany. A total of 617 patients (68.7% larynx; hypopharynx; 31.3%; 93.7% men; median age 62 years; 66.0% stage IV) from 2001 to 2020 were included. Kaplan–Meier and Cox multivariable regression analyses were performed. 23.7% of patients received a PEG. 74.7% received a VP. Median OS was 131 months. Independent factors for lower OS were stage IV (compared to stage II; hazard ratio [HR] = 3.455; confidence interval [CI] 1.395–8.556) and laryngectomy for a recurrent disease (HR = 1.550; CI 1.078–2.228). Median time to PEG removal was 7 months. Prior partial surgery before laryngectomy showed a tendency for independent association for later PEG removal (HR = 1.959; CI 0.921–4.167). Postoperative aspiration needing treatment was an independent risk factor (HR = 2.679; CI 1.001–7.167) for later definitive VP removal. Laryngectomy continuously plays an important role in a curative daily routine treatment setting of advanced laryngeal or hypopharyngeal cancer in Germany. Long-term dependency on nutrition via PEG is an important issue, whereas use of VP is a stable long-term measure for voice rehabilitation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Jena University Hospital, Department of Otorhinolaryngology, Jena, Germany (GRID:grid.275559.9) (ISNI:0000 0000 8517 6224)
2 Helios-Klinikum Erfurt, Department of Otorhinolaryngology, Erfurt, Germany (GRID:grid.491867.5) (ISNI:0000 0000 9463 8339)
3 SRH Zentralklinikum Suhl, Department of Otorhinolaryngology, Suhl, Germany (GRID:grid.491867.5)
4 Suedharzklinikum Nordhausen, Department of Otorhinolaryngology, Nordhausen, Germany (GRID:grid.491867.5)
5 SRH Wald-Klinikum Gera, Department of Otorhinolaryngology, Gera, Germany (GRID:grid.492124.8) (ISNI:0000 0001 0214 7565)
6 Sophien-Hufeland-Klinikum, Department of Otorhinolaryngology, Weimar, Germany (GRID:grid.459962.5) (ISNI:0000 0004 0482 8905)
7 Klinikum Bad Salzungen, Department of Otorhinolaryngology, Bad Salzungen, Germany (GRID:grid.459962.5)
8 Jena University Hospital, Department of Radiation Oncology, Jena, Germany (GRID:grid.275559.9) (ISNI:0000 0000 8517 6224)
9 Jena University Hospital, University Tumor Center, Jena, Germany (GRID:grid.275559.9) (ISNI:0000 0000 8517 6224)